Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- befree-20150227 importedOn "2015-02-27" NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_assertion wasGeneratedBy ECO_0000203 NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_assertion wasDerivedFrom befree-20150227 NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_assertion SIO_000772 22351695 NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_assertion evidence source_evidence_literature NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.
- NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_assertion description "[ON 01910.Na (Rigosertib), a multikinase phosphoinositide 3-kinase (PI3K) inhibitor, is entering phase III trials for myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625097.RAIEDxMcvK0kd4oQ_6Jdd_NqdcXDz_enpKze0Wf4_a_-Q130_provenance.